SEC Form 4 · accession 0001140361-17-010111
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Abdun-Nabi
Officer — President & CEO · Director
Period of report
Feb 27, 2017
Accepted (ET)
Mar 1, 2017 · 8:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2017 | M | 3,662 | $30.63 | A | 192,824 | D | |
| Common StockF1,F3 | Feb 27, 2017 | F | 1,735 | $30.63 | D | 191,089 | D | |
| Common StockF1,F4 | Feb 27, 2017 | F | 984 | $30.63 | D | 190,105 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option - (Right to Buy)F1,F2 | $14.51 | Feb 27, 2017 | M | 3,662 | D | Mar 8, 2013 | Mar 8, 2017 | Common stock | 3,662 | 0 | D |
Explanation of responses
- F1Consists of options granted under the Amended and Restated Emergent BioSolutions Inc 2006 Stock Incentive Plan, as amended.
- F2The option vested in three equal installments in March 2011, March 2012 and March 2013.
- F3Consists of shares owned by the reporting person and delivered to the issuer to satisfy the reporting persons exercise price for the reported stock options.
- F4Consists of shares withheld from the option exercise and delivered to the issuer to satisfy the reporting persons tax withholding obligations.